Evidence map›Paper›PMID 32847748›Full record

SynthesisJournal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi2021

Clinical features of neonates born to mothers with coronavirus disease-2019: A systematic review of 105 neonates.

Hsin Chi, Nan-Chang Chiu, Yu-Lin Tai, Hung-Yang Chang, Chao-Hsu Lin, Yi-Hsiang Sung, Cheng-Yin Tseng, Lawrence Yu-Min Liu, Chien-Yu Lin

Abstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Article
  8. Article
  9. Review
  10. COVID-19's Effect in Pregnancy and Vertical Transmission: A Systematic Review.International journal of preventive medicine · 2024
    Review
  11. Review
  12. Inhibition of IL-6 signaling prevents serum-induced umbilical cord artery dysfunction from patients with severe COVID-19.American journal of physiology. Regulatory, integrative and comparative physiology · 2023
    Article
  13. Review
  14. Article
  15. SARS-CoV-2 Infection in Pregnancy: Clues and Proof of Adverse Outcomes.International journal of environmental research and public health · 2023
    Observational
  16. Article
  17. Article
  18. Article
  19. Article
  20. Illness severity indicators in newborns by COVID-19 status in the United States, March-December 2020.Journal of perinatology : official journal of the California Perinatal Association · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hsin ChiDepartment of Pediatrics, MacKay Memorial Hospital, Taipei 104, Taiwan; Department of Medicine, MacKay Medical College, New Taipei 252, Taiwan. Electronic address: 4531.chi@mmh.org.tw.
Nan-Chang ChiuDepartment of Pediatrics, MacKay Memorial Hospital, Taipei 104, Taiwan; Department of Medicine, MacKay Medical College, New Taipei 252, Taiwan. Electronic address: ncc88@mmh.org.tw.
Yu-Lin TaiDepartment of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu 300, Taiwan. Electronic address: superlof@gmail.com.
Hung-Yang ChangDepartment of Pediatrics, MacKay Memorial Hospital, Taipei 104, Taiwan; Department of Medicine, MacKay Medical College, New Taipei 252, Taiwan. Electronic address: 4583@mmh.org.tw.
Chao-Hsu LinDepartment of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu 300, Taiwan; Department of Biological Science and Technology, National Chiao-Tung University, Hsinchu 300, Taiwan. Electronic address: 3099@mmh.org.tw.
Yi-Hsiang SungDepartment of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu 300, Taiwan. Electronic address: 6190@mmh.org.tw.
Cheng-Yin TsengDepartment of Internal Medicine and Evidence-Based Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu 300, Taiwan. Electronic address: 3074@mmh.org.tw.
Lawrence Yu-Min LiuDepartment of Medicine, MacKay Medical College, New Taipei 252, Taiwan; Department of Internal Medicine and Evidence-Based Medicine, Hsinchu MacKay Memorial Hospital, Hsinchu 300, Taiwan. Electronic address: drlawrenceliu@gmail.com.
Chien-Yu LinDepartment of Medicine, MacKay Medical College, New Taipei 252, Taiwan; Department of Pediatrics, Hsinchu MacKay Memorial Hospital, Hsinchu 300, Taiwan. Electronic address: mmhped.lin@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDespite the increasingly recognized impact of novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome (SARS) coronavirus 2 (SARS-CoV-2), on many aspects of health in adults and children, its effects on neonates born to infected mothers remain unclear. We conducted this study to investigate the outcomes of neonates born to mothers with COVID-19.

methodsWe searched the medical databases from inception to March 31, 2020 to perform a systematic review of outcomes in neonates born to mothers with COVID-19. Data were pooled using a random effects regression model. Primary and secondary outcomes were neonatal clinical outcomes and infectious status, respectively.

resultsFourteen studies involving 105 neonates fulfilling the study criteria were identified. The rates of preterm neonates and those small for gestational age (SGA) were 25 (23.8%) and 10 (11.2%), respectively. Among 91 neonates who were tested, 8 (8.8%) were positive for nucleic acids or antibodies for SARS-CoV-2. Additionally, 28 (26.7%) of the neonates were symptomatic and two test-negative neonates died, including one stillbirth. Between test-positive and test-negative groups, the rates of SGA, preterm delivery, duration between maternal symptom onset and delivery, and perinatal complication were not significantly different; but the rate of symptomatic after birth reached significant difference (62.5% vs 20.5%, p = 0.008).

conclusionsMost neonates born to infected mothers had favorable outcomes. Although direct evidences of intrauterine infection were scarce, the risk of intrauterine infection should be considered based on a positive test in 8.8% of the neonates. Symptomatic neonates born to infected mothers should receive tests for SARS-CoV-2 to initiate appropriate treatment and quarantine. Further studies are warranted to assess the outcomes of COVID-19 in neonates.

Indexed as

Infectious Disease Transmission, VerticalCOVID-19Databases, FactualFemaleHumansInfant, NewbornMothersPregnancyPregnancy Complications, InfectiousRisk FactorsCOVID-19Intrauterine infectionNeonateNovel coronavirusSARS-CoV-2Vertical transmission

Identifiers

PMID32847748
PMCPMC7427525

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.